Sean M. Healey & AMG Center for ALS
The ALS Association today announced a $3 million commitment to the first platform trial for ALS, taking place at the Sean M. Healey & AMG Center for ALS at Mass General in collaboration with the Barrow Neurological Institute and the Northeast ALS Consortium (NEALS).
Read articleSabrina Paganoni, MD, PhD, is quoted in an article about ALS care, describing positive outcomes for patients using ventilators to assist their breathing.
Merit Cudkowicz, MD and Sabrina Paganoni, MD, PhD, are interviewed in an article about their study of a new ALS treatment showing strong results in phase 2 trials.
Join our quest to discover life-saving therapies for individuals who are affected by ALS. The key to our success is our dedication to collaboration. At the Sean M. Healey and AMG Center for ALS at Mass General, we partner with the best clinician-scientists, our patients and friends like you to turn laboratory successes into promising therapies.
